Product Information

FEBUXOSTAT 80 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2570 per EA under NDC 62332019130. Its NADAC has been published 375 times since Sep 18, 2019.

FDA first approved this application on Jul 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FEBUXOSTAT 80 MG TABLET

febuxostat
$0.2570per EA

Strength

80 mg/1

NDC

62332019130

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA205421

FDA Approved

7/1/2019

TE Code

AB

On Market Since

7/1/2019

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 80 MG TABLET has been published 375 times since Sep 18, 2019, and over the history we have for it it has declined 96.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2570 per EA
All-time high$7.7179 (Oct 16, 2019)
All-time low$0.2502 (Oct 21, 2026)
52-week high$0.3536
52-week low$0.2502
Median price$0.6639
Average price$1.2192
Largest weekly change+46.7% (Feb 22, 2023)
Weeks tracked375
Tracking sinceSep 18, 2019

Price History

1W

+2.7%

1M

-1.5%

3M

-8.5%

6M

-27.3%

1Y

-26.6%

3Y

-60.2%

5Y

-66.8%

All

-96.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.2570 per EA (NDC 62332019130), effective Nov 18, 2026.

How has the price of FEBUXOSTAT 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 96.7%. It has been tracked across 375 weekly CMS publications since Sep 18, 2019.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?

Since Sep 18, 2019, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2502 (Oct 21, 2026) to a high of $7.7179 (Oct 16, 2019), with a median of $0.6639 per EA.

Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 80 MG TABLET?

FEBUXOSTAT 80 MG TABLET (NDC 62332019130) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.